368 related articles for article (PubMed ID: 16636304)
1. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
Ness GC; Holland RC; Lopez D
Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity to dietary cholesterol in diabetic and hypothyroid rats associated with low levels of hepatic HMG-CoA reductase expression.
Ness GC; Gertz KR
Exp Biol Med (Maywood); 2004 May; 229(5):407-11. PubMed ID: 15096652
[TBL] [Abstract][Full Text] [Related]
3. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
4. Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol.
Ness GC; Gertz KR
Exp Biol Med (Maywood); 2004 May; 229(5):412-6. PubMed ID: 15096653
[TBL] [Abstract][Full Text] [Related]
5. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.
Gouni-Berthold I; Berthold HK; Gylling H; Hallikainen M; Giannakidou E; Stier S; Ko Y; Patel D; Soutar AK; Seedorf U; Mantzoros CS; Plat J; Krone W
Atherosclerosis; 2008 May; 198(1):198-207. PubMed ID: 17980884
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.
Ness GC; Lopez D; Chambers CM; Newsome WP; Cornelius P; Long CA; Harwood HJ
Biochem Pharmacol; 1998 Jul; 56(1):121-9. PubMed ID: 9698096
[TBL] [Abstract][Full Text] [Related]
7. Compensatory responses to inhibition of hepatic squalene synthase.
Lopez D; Chambers CM; Keller RK; Ness GC
Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
[TBL] [Abstract][Full Text] [Related]
8. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
[TBL] [Abstract][Full Text] [Related]
9. Dietary cholesterol regulates hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in rats primarily at the level of translation.
Chambers CM; Ness GC
Arch Biochem Biophys; 1998 Jun; 354(2):317-22. PubMed ID: 9637742
[TBL] [Abstract][Full Text] [Related]
10. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine.
Feingold KR; Wilson DE; Wood LC; Kwong LK; Moser AH; Grunfeld C
Metabolism; 1994 Apr; 43(4):450-4. PubMed ID: 8159102
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
Liang K; Vaziri ND
Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia.
Wu N; Sarna LK; Siow YL; O K
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R635-43. PubMed ID: 21178122
[TBL] [Abstract][Full Text] [Related]
13. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
Ness GC; Zhao Z; Keller RK
Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
[TBL] [Abstract][Full Text] [Related]
14. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity.
Ness GC; Chambers CM
Proc Soc Exp Biol Med; 2000 May; 224(1):8-19. PubMed ID: 10782041
[TBL] [Abstract][Full Text] [Related]
15. Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
Feingold KR; Pollock AS; Moser AH; Shigenaga JK; Grunfeld C
J Lipid Res; 1995 Jul; 36(7):1474-82. PubMed ID: 7595071
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase.
Yiu WF; Kwan PL; Wong CY; Kam TS; Chiu SM; Chan SW; Chan R
J Food Sci; 2011 Apr; 76(3):H80-9. PubMed ID: 21535835
[TBL] [Abstract][Full Text] [Related]
17. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
Yu L; Qiu S; Genest J
Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin.
Nguyen LB; Shefer S; Salen G; Tint GS; Ruiz F; Bullock J
J Lipid Res; 2001 Feb; 42(2):195-200. PubMed ID: 11181748
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hepatic sterol metabolism in the rat. Parallel regulation of activity and mRNA for 7 alpha-hydroxylase but not 3-hydroxy-3-methylglutaryl-coenzyme A reductase or low density lipoprotein receptor.
Spady DK; Cuthbert JA
J Biol Chem; 1992 Mar; 267(8):5584-91. PubMed ID: 1544932
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
Liang K; Kim CH; Vaziri ND
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
